SeekingAlpha · Aug 13, 2026
abrdn Life Sciences Investors Q2 2026 Commentary
The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. Read more here.
HQ
NYSE · HQL
Tekla Life Sciences Investors
Financial Services · Asset Management
$21.67
Up+$0.12 (+0.56%)
Updated Aug 26, 2026, 6:56 AM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 497.33M
- P/E ratio
- -40.78
- Dividend yield
- 8.40%
- 52-week range
- $15.82 – $22.67
- Volume
- 146.92K
- Avg. volume
- 194.28K
Price performance
HQL price history
1M range · 0 trading sessions · Daily adjusted prices
HQL does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest HQL news
The latest Smart Investors Daily articles mentioning HQL.
Stock researchCompany · Overview
HQL research
Overview
Company profile and research snapshot.
Company profile
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Feb 25, 2026
Abrdn Life Sciences Investors Fund Q4 2025 Commentary
Yahoo · Feb 10, 2026
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), t
SeekingAlpha · Jan 28, 2026
HQL: Dividend Can Be Sustained Through 2026
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
